Genotyping May Boost Antidepressant Treatment Success Genotyping May Boost Antidepressant Treatment Success

Impairments in the gene that encodes the enzyme responsible for metabolizing the antidepressant escitalopram may be responsible for treatment failure.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Psychiatry News Source Type: news